Quantitative Sensory Testing and PET/CT Scanning in Assessment of Surgical Outcome for Lumbar Disc Herniation (PET-Pain)
Primary Purpose
Lumbar Disc Herniation, Radiculopathy Lumbar
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PET/CT scan
Quantitative Sensory Testing
Sponsored by
About this trial
This is an interventional basic science trial for Lumbar Disc Herniation focused on measuring PET/CT
Eligibility Criteria
Inclusion Criteria:
- Informed consent
- Clinical and radiological indication for LDH surgery, assessed by an experienced spinal surgeon
- Age 40-65 years
- Able to comply with regulations regarding medicine consumption (stated below)
Exclusion Criteria:
- History of previous spine surgery
- General contra-indication for spine surgery
- Greatly reduced kidney function
- Diagnosis of psychiatric disorder
- Current malignant disease
- History of radiation therapy
- Current chemotherapy
- History of spinal fracture
- Hematologic disease
- Current pregnancy or breast-feeding
- Chronic, generalized connective tissue disorders or chronic, non-specific pain disorders (fibromyalgia, whiplash (WAD I-V), etc.)
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
General
Arm Description
All subjects will undergo ordinary surgical treatment for their lumbar disc herniation. Experimentally, all subjects participating in the study will receive PET/CT scans and sensory testing as specified below.
Outcomes
Primary Outcome Measures
EuroQol-5D 3L
The 3-level version of EQ-5D (EQ-5D-3L) was introduced in 1990 by the EuroQol Group.
The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement.
Oswestry Disability Index
The Oswestry Disability Index (also known as the Oswestry Low Back Pain Disability Questionnaire) is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability. The test is considered the 'gold standard' of low back functional outcome tools.
0% to 20%: minimal disability: The patient can cope with most living activities.
21%-40%: moderate disability: The patient experiences more pain and difficulty with sitting, lifting and standing. Travel and social life are more difficult, and they may be disabled from work. 41%-60%: severe disability: Pain remains the main problem in this group but activities of daily living is affected. These patients require a detailed investigation. 61%-80%: crippled: Back pain impinges on all aspects of the patient's life. 81%-100%: These patients are either bed-bound or exaggerating their symptoms.
Visual Analogue Scale
Both leg and back.
Measure 0-100. 0 being no pain. 100 being worst imaginable pain.
Secondary Outcome Measures
Full Information
NCT ID
NCT03894943
First Posted
March 27, 2019
Last Updated
April 2, 2019
Sponsor
Spine Centre of Southern Denmark
Collaborators
Odense University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03894943
Brief Title
Quantitative Sensory Testing and PET/CT Scanning in Assessment of Surgical Outcome for Lumbar Disc Herniation
Acronym
PET-Pain
Official Title
Quantitative Sensory Testing and PET/CT Scanning in Assessment of Surgical Outcome for Lumbar Disc Herniation
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
June 2014 (Actual)
Primary Completion Date
November 2018 (Actual)
Study Completion Date
November 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Spine Centre of Southern Denmark
Collaborators
Odense University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Patients with lumbar disc herniation suffer from pain and morbidity. Surgical intervention can be a quick and effective relief, however some individuals experience less favorable outcome.
This study tries to investigate and test the differences in pain perception and pain modulation between individuals. Using PET/CT scans the investigators try to visualize pain perception and -modulation in the CNS. This is subsequently correlated with a battery of pain tests and the surgical outcome of disc herniation surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Disc Herniation, Radiculopathy Lumbar
Keywords
PET/CT
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
61 (Actual)
8. Arms, Groups, and Interventions
Arm Title
General
Arm Type
Experimental
Arm Description
All subjects will undergo ordinary surgical treatment for their lumbar disc herniation. Experimentally, all subjects participating in the study will receive PET/CT scans and sensory testing as specified below.
Intervention Type
Diagnostic Test
Intervention Name(s)
PET/CT scan
Intervention Description
Patient receive a PET/CT scan of their cerebrum and lumbar spine prior to surgery, 4-6 weeks after surgery and 6 months after surgery
Intervention Type
Diagnostic Test
Intervention Name(s)
Quantitative Sensory Testing
Intervention Description
Patients undergo a battery of quantitative sensory tests prior to surgery, 4-6 weeks after surgery and 6 months after surgery
Primary Outcome Measure Information:
Title
EuroQol-5D 3L
Description
The 3-level version of EQ-5D (EQ-5D-3L) was introduced in 1990 by the EuroQol Group.
The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement.
Time Frame
1 year
Title
Oswestry Disability Index
Description
The Oswestry Disability Index (also known as the Oswestry Low Back Pain Disability Questionnaire) is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability. The test is considered the 'gold standard' of low back functional outcome tools.
0% to 20%: minimal disability: The patient can cope with most living activities.
21%-40%: moderate disability: The patient experiences more pain and difficulty with sitting, lifting and standing. Travel and social life are more difficult, and they may be disabled from work. 41%-60%: severe disability: Pain remains the main problem in this group but activities of daily living is affected. These patients require a detailed investigation. 61%-80%: crippled: Back pain impinges on all aspects of the patient's life. 81%-100%: These patients are either bed-bound or exaggerating their symptoms.
Time Frame
1 year
Title
Visual Analogue Scale
Description
Both leg and back.
Measure 0-100. 0 being no pain. 100 being worst imaginable pain.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Informed consent
Clinical and radiological indication for LDH surgery, assessed by an experienced spinal surgeon
Age 40-65 years
Able to comply with regulations regarding medicine consumption (stated below)
Exclusion Criteria:
History of previous spine surgery
General contra-indication for spine surgery
Greatly reduced kidney function
Diagnosis of psychiatric disorder
Current malignant disease
History of radiation therapy
Current chemotherapy
History of spinal fracture
Hematologic disease
Current pregnancy or breast-feeding
Chronic, generalized connective tissue disorders or chronic, non-specific pain disorders (fibromyalgia, whiplash (WAD I-V), etc.)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Støttrup, MD
Organizational Affiliation
Sygehus Lillebælt
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Following completion of the study, data obtained during the research project will be made available to other researchers using Mendeleys sharing platform
IPD Sharing Time Frame
Will be shared late 2020
Learn more about this trial
Quantitative Sensory Testing and PET/CT Scanning in Assessment of Surgical Outcome for Lumbar Disc Herniation
We'll reach out to this number within 24 hrs